Early Post-Operative Rehabilitation in Thyroid Cancer Patients Post-Transaxillary Robot-Assisted Surgery: A New Treatment Option

Strategic Insights -

The Yonsei University Health System's Gangnam Severance Hospital in South Korea has conducted a clinical trial to investigate the efficacy of early post-operative rehabilitation in patients with thyroid cancer who underwent transaxillary robot-assisted surgery. The primary objective of the study is to determine whether early patient education and rehabilitation can reduce postoperative pain and accelerate functional recovery. By focusing on early patient education and rehabilitation, the researchers aim to propose a new and effective treatment option for pain and functional recovery after transaxillary robotic thyroidectomy.

Key Takeaways:

  • The clinical trial aims to investigate the efficacy of early post-operative rehabilitation in reducing postoperative pain and accelerating functional recovery in thyroid cancer patients who underwent transaxillary robot-assisted surgery.
  • The study involves two groups: the Control Group (Education Group) and the Rehabilitation Group, with the latter receiving physical therapy in addition to postoperative care and exercise training.
  • The researchers will assess the primary hypothesis that the Rehabilitation Group will experience greater pain reduction than the Education Group.
  • Secondary hypotheses include improved functional recovery, better activities of daily living, reduced depression, and reduced anxiety in the Rehabilitation Group.
  • The study constitutes an initial step towards developing a new treatment option for pain and functional recovery after transaxillary robotic thyroidectomy.

Statistics:

  • The duration of the transaxillary robot-assisted surgery ranges from 1-2 hours.
  • The study focuses on thyroid cancer patients who underwent transaxillary robot-assisted surgery.
  • The Clinical Research Information Service (CRiS) registration number for the clinical trial is KCT0010943.
  • The study type is Interventional, with a primary hypothesis focusing on pain reduction and secondary hypotheses addressing functional recovery and psychological well-being.

Sources:

  • Clinical Research Information Service (CRIS) - Republic of Korea
  • Clinical Trial Registration Number: KCT0010943
  • Full-text of the clinical trial: https://cris.nih.go.kr/cris/search/detailSearch.do?seq=30999&search_page=L